Two major pharmaceutical companies developing advanced-stage R&D on Alzheimer’s disease have just pulled the plug on their research. The reason why their approach to Alzheimer’s, Aducanumab, failed is because it didn’t account for a factor that is central
to R&D conducted by biotechnology Company ProMIS Neurosciences Inc.
(TSX:PMN, OTCQB:ARFXF, Forum).
Preclinical studies show the Company's lead antibody candidate, PMN310,
demonstrates a high degree of binding to toxic oligomers from Alzheimer's disease brains without binding to plaque or other non-toxic forms of the toxic oligomer form of
amyloid beta (Aβ).
Not only has an important competitor dropped out of the race to find an Alzheimer’s
treatment, the reason for failure suggests that ProMis is on the right track with its own
research.
Stockhouse is joined by Company President and CEO, Dr. Elliot Goldstein to learn
more about ProMIS’ research and potential to combat Alzheimer’s Disease.
Iron Ore & Vanadium in Quebec: Who’s Driving BOTH Markets?
The Company That’s Delivering Safe, Evidence-Based Psychedelic-Assisted Psychotherapies
Stockhouse Podcast - ImaginAR
A ‘Barrier’ to Better Health
A Psychedelic & Nutraceutical Opportunity: A Boost for the Brain and Your Portfolio
Profiting from Protection: The Power of Permission-Based Partner Programs
A Major Helium Play Readies to Make its Stock Even More Valuable
Hire Tech. Interview with CEO Simon Dealy
Bee Vectoring Podcast
A Potential Psychedelic and COVID Therapy Play…All in One Stock
The ‘Lean Mean Fighting Machine’ That’s Redefining the Cannabis 2.0 Marketplace
The Company that’s offering Real Contactless Solutions During COVID-19
Increased Cannabis Interest Paves Way for Cannabinoid Production
Prospecting the Americas While Generating Real Shareholder Value
Tapping Into a Legendary Mine
Ahead of the Competition and Poised for Ridesharing Growth
A New Solution for the Multibillion-Dollar Bladder Cancer Problem
A New, United Frontier for Gold & Crypto Markets
Staffing as an Essential Service. Taking the Industry to a Whole New Level.
Cultivating. Innovating. Operating: Discovering the Science of CBD
Create your
podcast in
minutes
It is Free
The Commercial Edge: Unleash the Power of People
The emPOWERed Half Hour
U.S Property Podcast
Aligned Money Show
Dubai Property Podcast
The Ramsey Show
The Clark Howard Podcast